Articles - Page 5 of 90 - Drugs in Context

The magnitude and predictors of self-medication amongst street dwellers in Ethiopia: a multicentre study

Tirsit Ketsela Zeleke, Bekalu Dessie Alamirew, Zegaye Agmassie Bazezew, Muluken Adela Alemu, Abdisa Gemedi Jara, Rahel Belete Abebe

Article Type

Original Research

Published

11 Jan 2024

This study provides insight into self-medication use and predictors amongst street dwellers in Ethiopia.

Review and expert opinion on MAFLD, oxidative stress and multifunctional management

Francesco Angelico, Diana Alcantara-Payawal, Rafiz Abdul Rani, Norlaila Mustafa, Nuntakorn Thongtang, Roongruedee Chaiteerakij, Chalermrat Bunchorntavakul, Apichard Sukonthasarn

Article Type

Review

Published

10 Jan 2024

This review summarizes the current knowledge about metabolic-associated fatty-liver disease (MAFLD) and reports the opinion of a group of experts on the increasing prevalence and burden of the disease in the southeast Asia region, the current journey of patients with MAFLD in developing countries, the role of oxidative stress and antioxidant treatment, and the importance of a multidisciplinary approach for early diagnosis and disease management.

Diuretic resistance and the role of albumin in congestive heart failure

Carol Fernandez Hazim, Gustavo Duarte, Ana P Urena, Swati Jain, Rishabh Mishra, Timothy J Vittorio, Miguel Rodriguez-Guerra

Article Type

Review

Published

29 Dec 2023

This review aims to expose the multiple approaches for treatment of patients with diuretic resistance and the importance of intravascular volume expansion in the response to therapy.

Corrigendum: Precautions in the management of opioid agonist therapy: from target population characteristics to new formulations and post-marketing monitoring – a focus on the Italian system

Guido Mannaioni, Fabio Lugoboni

Article Type

Corrigendum

Published

20 Dec 2023

The authors wish to make the following corrections to their article: Mannaioni G, Lugoboni F. Precautions in the management of opioid agonist therapy: from target population characteristics to new formulations and post-marketing monitoring – a focus on the Italian system. Drugs Context. 2023;12:2023-2-6. https://doi.org/10.7573/dic.2023-2-6

Efficacy and safety of itopride SR for upper gastrointestinal symptoms in patients with diabetic gastroparesis: real-world evidence from Pakistan

Adil Ramzan, Ghulam Fareed Memon, Asif Ali, Muhammad Masood, Tariq Meher, Adnan Ghafoor, Naveed Ahmed Shehzad, Safian Ahmed, Zunaira Nawaz, Muhammad Rehan, Tariq Saeed, Waqar Taj, Sakhawat Abbass, Ramiz Khan, Hamza Ehsan, Abubakkar Alam, Bilal Manzoor, Muhammad Nawaz Khan, Khalid Mahmood Yahya, Farhan Mukhtiar, Muhammad Asif Javed, Muhammad Usman Sheikh, Danish Janjua, Sumerah Jabeen, Junaid Zafar, Riaz Hussain Khokar, Madeeha Nazar, Neeta Maheshwary, Muhammad Athar Khan

Article Type

Original Research

Published

19 Dec 2023

This study aims to evaluate the efficacy and safety of itopride in addressing upper gastrointestinal symptoms associated with gastroparesis specifically in patients with diabetes. By assessing the impact of itopride SR on symptom relief, this research intends to provide valuable insights into the potential benefits of itopride as a treatment option for gastroparesis.